Literature DB >> 6407054

Effects of a 1,5-benzodiazepine derivative upon performance in an experimental stress situation.

A C Parrott, S Davies.   

Abstract

Psychological performance tasks were given to normal subjects under different conditions of experimental stress: high stress (being filmed on video), or low stress (tested without filming); and after different pharmacological treatments: clobazam 20 mg (an anxiolytic 1,5-benzodiazepine derivative), or placebo. On all five performance assessments (choice reaction times, serial subtraction times, critical flicker fusion values), there was a consistent tendancy for clobazam performance to be comparatively better under high stress, and for placebo performance to be comparatively better under low stress. From these, and previous similar findings, it seems that the level of experimental "stress" under which subjects are tested, can have important influences upon the psychopharmacological performance levels obtained.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6407054     DOI: 10.1007/BF00433420

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  7 in total

1.  Critical flicker frequency (CFF) and psychotropic drugs in normal human subjects-a review.

Authors:  J M Smith; H Misiak
Journal:  Psychopharmacologia       Date:  1976-05-28

Review 2.  Differential psychopharmacology of tranquilizing and sedating drugs.

Authors:  W Janke; G Debus; N Longo
Journal:  Mod Probl Pharmacopsychiatry       Date:  1979

3.  Clobazam. A 1.5 benzodiazepine derivative: effects upon human psychomotor performance under different levels of task reinforcement.

Authors:  A C Parrott; I Hindmarch
Journal:  Arch Int Pharmacodyn Ther       Date:  1978-04

4.  Defining tranquilizers operationally by non additive effect in experimental stress situations.

Authors:  R Kohnen; G A Lienert
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

5.  Some aspects of the effects of clobazam on human psychomotor performance.

Authors:  I Hindmarch
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

6.  Personal constructs of anxiety under the 1,5-benzodiazepine derivative clobazam related to trait-anxiety levels of the personality.

Authors:  A C Parrott; R Kentridge
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

7.  The effects of repeated nocturnal doses of clobazam, dipotassium chlorazepate and placebo on subjective ratings of sleep and early morning behaviour and objective measures of arousal, psychomotor performance and anxiety.

Authors:  I Hindmarch; A C Parrott
Journal:  Br J Clin Pharmacol       Date:  1979-10       Impact factor: 4.335

  7 in total
  2 in total

1.  Risks of dependence on benzodiazepine drugs: a major problem of long term treatment.

Authors:  H Ashton
Journal:  BMJ       Date:  1989-01-14

2.  Differential effect of benzodiazepine sedation in high and low anxious patients in a "real life" stress setting.

Authors:  C A O'Boyte; D Harris; H Barry; J H Cullen
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.